Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fabian Fischer
Observed name:
Fischer, Fabian
Institutions:
HES-SO University of Applied Sciences and Arts Western Switzerland,
HES-SO Valais-Wallis,
Institute of Life Sciences
Observed institutions:
HES-SO University of Applied Sciences and Arts Western Switzerland,
Friedrich-Alexander-Universität Erlangen-Nürnberg,
University Hospital Regensburg,
Universitätsklinikum Erlangen,
HES-SO Valais-Wallis,
Institute of Life Sciences,
Heinrich Heine University Düsseldorf
show all 7
ORCID:
0000-0003-1140-2024
Observed ORCID:
0000-0003-1140-2024
OpenAlex ID:
A5071664903
Designing HDAC-PROTACs: Lessons Learned So Far
2021
·
Fabian Fischer
, Leandro A Alves Avelar
, et al.
·
Future Medicinal Chemistry
·
38
Limitation of TCA Cycle Intermediates Represents an Oxygen-Independent Nutritional Antibacterial Effector Mechanism of Macrophages
2019
·
Inaya Hayek
, Fabian Fischer
, et al.
·
Cell Reports
·
38
PDF
Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies
2022
·
Aaron Burmeister
, Alexa Stephan
, et al.
·
Molecular Cancer Therapeutics
·
26
PDF
5-(Trifluoromethyl)-1,2,4-oxadiazole (TFMO)-based highly selective class IIa HDAC inhibitors exhibit synergistic anticancer activity in combination with bortezomib
2023
·
Yodita Asfaha
, Lukas M. Bollmann
, et al.
·
European Journal of Medicinal Chemistry
·
22
Deciphering the Therapeutic Potential of Novel Pentyloxyamide-Based Class I, IIb HDAC Inhibitors against Therapy-Resistant Leukemia
2024
·
Fabian Fischer
, Julian Schliehe-Diecks
, et al.
·
Journal of Medicinal Chemistry
·
15
YAK577 Attenuates Cardiac Remodeling and Fibrosis in Isoproterenol-Infused Heart Failure Mice by Downregulating MMP12
2024
·
Hongyan Zhou
, Hae Jin Kee
, et al.
·
Korean Circulation Journal
·
13
PDF
Antiproliferation and Antiencystation Effect of Class II Histone Deacetylase Inhibitors on Acanthamoeba castellanii
2022
·
Ki-Back Chu
, Hae-Ahm Lee
, et al.
·
ACS Infectious Diseases
·
12
A Short Overview of Resistance to Approved Histone Deacetylase Inhibitors
2021
·
Fabian Fischer
, Leandro A Alves Avelar
·
Future Medicinal Chemistry
·
8
Three Small Molecule Entities (MPK18, MPK334 and YAK308) with Activity against Haemonchus contortus In Vitro
2021
·
Aya C. Taki
, Abdul Jabbar
, et al.
·
Molecules
·
7
PDF
Epigenetic targeting of DNA damage response (DDR)-related mechanisms to overcome acquired cisplatin resistance of tumor cells
2025
·
Marlena Sekeres
, Daniel Lengle
, et al.
·
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
·
6
Antiplasmodial activity of pentyloxyamide-based histone deacetylase inhibitors against Plasmodium falciparum parasites
2025
·
Wisam A. Dawood
, Gillian M. Fisher
, et al.
·
International Journal for Parasitology Drugs and Drug Resistance
·
3
Potentials and kinetics in electron uptake by Sporomusa ovata in microbial electrosynthesis
2026
·
Jérémie Noël
, Michele Morgante
, et al.
·
Chemical Engineering Journal
·
1
Supplementary Data from Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies
2023
·
Aaron Burmeister
, Alexa Stephan
, et al.
Supplementary Data from Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies
2023
·
Aaron Burmeister
, Alexa Stephan
, et al.
Supplementary Data from Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies
2023
·
Aaron Burmeister
, Alexa Stephan
, et al.
Supplementary Data from Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies
2023
·
Aaron Burmeister
, Alexa Stephan
, et al.
Supplementary Data from Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies
2023
·
Aaron Burmeister
, Alexa Stephan
, et al.
Supplementary Data from Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies
2023
·
Aaron Burmeister
, Alexa Stephan
, et al.
Supplementary Data from Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies
2023
·
Aaron Burmeister
, Alexa Stephan
, et al.
Supplementary Data from Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies
2023
·
Aaron Burmeister
, Alexa Stephan
, et al.
Data from Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies
2023
·
Aaron Burmeister
, Alexa Stephan
, et al.
Data from Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies
2023
·
Aaron Burmeister
, Alexa Stephan
, et al.
Show more works
View as search
Works count:
23
Citation count:
189
H-index:
8
I10-index:
7
Year
Topic
Type